Currently Viewing:
Newsroom
Currently Reading
A Significant Unmet Mental Health Care Need Exists for Patients With COPD
August 25, 2019 – Kelly Davio
Medicaid Expansion Linked to Increased HIV Testing
August 24, 2019 – Jaime Rosenberg
5 Things to Look for at the European Society of Cardiology 2019 Congress
August 23, 2019 – Mary Caffrey
Phase I Pancreatic Cancer Trial Identifies Effective Combination Treatment
August 23, 2019 – Alison Rodriguez
AJMC® in the Press, August 23, 2019
August 23, 2019 – AJMC Staff
Fatal AEs Associated With Alemtuzumab for MS May Occur More Frequently Than Previously Thought
August 23, 2019 – Laura Joszt
What We're Reading: ACA Plan Offerings Expand; Combo Pill Cuts CV Events; Biosimilar Savings
August 23, 2019 – AJMC Staff
This Week in Managed Care: August 23, 2019
August 23, 2019
HHS Proposes Easing Privacy Restrictions for Patients With History of Substance Use Disorder
August 22, 2019 – Jaime Rosenberg

Pfizer Gains Access to 23andMe's Genetic Mine

23andMe is betting its growing troves of genetic data will prove essential to drug companies, medical researchers, and even health and wellness companies.
23andMe Inc., the genetic-testing startup backed by Google Inc. (GOOG), is sharing DNA data on about 650,000 individuals with Pfizer Inc. (PFE), to help find new targets to treat disease and to design clinical trials.

The collaboration with Pfizer is the broadest announced so far in 23andMe’s ambitious plan to become a repository for humanity’s genetic makeup, and to turn data gathered from $99 saliva tests sold to consumers into multimillion-dollar deals with drugmakers.

The agreement unveiled today gives the U.S.’s largest drugmaker access to anonymous, aggregated information from consumers who bought 23andMe’s test over the past seven years to learn about their own genetic histories. It includes only people who agreed to let their data be used in research. Pfizer and 23andMe declined to give the deal’s value.

Reported on Bloomberg: http://bloom.bg/1xhimt3

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up